Urotensin II Induces Rat Cardiomyocyte Hypertrophy via the Transient Oxidization of Src Homology 2-Containing Tyrosine Phosphatase and Transactivation of Epidermal Growth Factor Receptor

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Pharmacology

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.109.058297PMID 19755521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts.

  2008influential reference
• Urotensin-II and cardiovascular remodeling.

  2008cited by this paper
• Remodeling of Gap Junctions in Ischemic and Nonischemic Forms of Heart Disease

  2007cited by this paper
• Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol

  2007cited by this paper
• Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells.

  2007cited by this paper
• Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling

  2006cited by this paper
• Urotensin-II and cardiovascular diseases

  2006cited by this paper
• Reactive Oxygen Species Generation Is Involved in Epidermal Growth Factor Receptor Transactivation through the Transient Oxidization of Src Homology 2-Containing Tyrosine Phosphatase in Endothelin-1 Signaling Pathway in Rat Cardiac Fibroblasts

  2006influential reference
• Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.

  2005influential reference
• Nitric Oxide Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy through cGMP-mediated Suppression of Extracellular-Signal Regulated Kinase Phosphorylation

  2005influential reference
• Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells

  2005cited by this paper
• Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy

  2004cited by this paper
• Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.

  2004cited by this paper
• Urotensin II and cardiovascular diseases.

  2004cited by this paper
• Regulation of Insulin Signaling through Reversible Oxidation of the Protein-tyrosine Phosphatases TC45 and PTP1B*

  2004cited by this paper
• Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1.

  2003cited by this paper
• Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy

  2003cited by this paper
• Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo.

  2002influential reference
• Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats

  2001cited by this paper
• Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling.

  2000cited by this paper
• Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes.

  1999cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Institute of Laboratory Animal Resources.

  1995cited by this paper

• Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation

  2025cites this paper
• Signalling pathways involved in urotensin II induced ventricular myocyte hypertrophy

  2025cites this paper
• Hibiscus syriacus L. Exhibits Cardioprotective Activity via Anti-Inflammatory and Antioxidant Mechanisms in an In Vitro Model of Heart Failure

  2025cites this paper
• The complicated lives of GPCRs in cardiac fibroblasts.

  2022cites this paper
• The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions.

  2022cites this paper
• GPCR-ErbB transactivation pathways and clinical implications.

  2021cites this paper
• Effects of Resveratrol on the Level of Urotensin II and its Receptors in the Homogenized Tissue of Diabetic Rats

  2020cites this paper
• Cafestol Activates Nuclear Factor Erythroid-2 Related Factor 2 and Inhibits Urotensin II-Induced Cardiomyocyte Hypertrophy.

  2019cites this paper
• Inhibitory Effects of Momordicine I on High-Glucose-Induced Cell Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts

  2018cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells

  2017cites this paper
• Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.

  2017cites this paper
• Cardiac GPCR–Mediated EGFR Transactivation: Impact and Therapeutic Implications

  2017cites this paper
• The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features

  2017cites this paper
• Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.

  2016cites this paper
• Genetic polymorphisms of UTS2 rs2890565 Ser89Asn in cardiac hypertrophy in Chinese Han population

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy

  2015cites this paper
• Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

  2015cites this paper
• Effects of urotensin II on intracellular pH regulation in cultured human internal mammary artery smooth muscle cells.

  2014cites this paper
• Urotensin II Induces Interleukin 8 Expression in Human Umbilical Vein Endothelial Cells

  2014cites this paper
• Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes

  2014cites this paper
• Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.

  2014cites this paper
• The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer

  2014cites this paper
• Regulation of Protein Tyrosine Phosphatase Oxidation in Cell Adhesion and Migration

  2014cites this paper
• Role of the SHP2 Protein Tyrosine Phosphatase in Cardiac Metabolism

  2013cites this paper
• The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells.

  2013cites this paper
• Rôle des déterminants moléculaires impliqués dans la signalisation du récepteur urotensine II

  2013cites this paper
• Anticarcinogenic Effects of the Ethanolic Extract of Salix aegyptiaca in Colon Cancer Cells: Involvement of Akt/PKB and MAPK Pathways

  2013cites this paper
• Redox-regulation of PTPs; mechanisms and impact on PDGFR signaling

  2013cites this paper
• Contractile responses to rat urotensin II in resting and depolarized basilar arteries

  2013cites this paper
• Potential Markers in Cardiac Hypertrophy?

  2012cites this paper
• Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK.

  2012cites this paper
• EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy

  2011influential citation
• Regulation of protein tyrosine phosphatases by reversible oxidation.

  2011influential citation
• Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.

  2010cites this paper
• GSK1562590, a slowly dissociating urotensin‐II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo

  2010cites this paper